Phase 2
-
CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer
Phase 2 · randomised · 192 people · 1 site in China · Recruiting now
-
FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
Phase 2 · 26 people · 1 site in United States · Recruiting now
-
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Phase 2 · randomised · 134 people · 2 sites in United States · Recruiting now
-
Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
Phase 2 · randomised · 236 people · 1 site in China · Recruiting now
-
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer
Phase 2 · 197 people · 1 site in Italy · Recruiting now
-
A Study of DM002 in Patients With Advanced Solid Tumors
Phase 2 · 280 people · 7 sites in 2 countries · Recruiting now
-
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer
Phase 2 · 60 people · 14 sites in United States · Recruiting now